Search Results

You are looking at 1 - 10 of 18 items for :

  • late effects x
  • Pituitary and Hypothalamus x
Clear All
Izabelle Lövgren Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Search for other papers by Izabelle Lövgren in
Google Scholar
PubMed
Close
,
Azadeh Abravan Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Azadeh Abravan in
Google Scholar
PubMed
Close
,
Abigail Bryce-Atkinson Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Search for other papers by Abigail Bryce-Atkinson in
Google Scholar
PubMed
Close
, and
Marcel van Herk Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Marcel van Herk in
Google Scholar
PubMed
Close

efficacy and detrimental side effects, such as secondary neoplasms and endocrine deficiencies, is still needed. As the survival rate has also increased, patients are now living long enough to see these late effects. Common oncological treatments include

Open access
David S McLaren Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by David S McLaren in
Google Scholar
PubMed
Close
,
Aarani Devi Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by Aarani Devi in
Google Scholar
PubMed
Close
,
Nikolaos Kyriakakis Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed
Close
,
Michelle Kwok-Williams Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed
Close
, and
Robert D Murray Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK
Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Robert D Murray in
Google Scholar
PubMed
Close

disease; however, an increase in cardiovascular mortality ( 5 ) and risk of early- and late-occurring stroke ( 6 , 7 ) are also observed. As a consequence, survivors are more likely to be hospitalised compared with the general population. Effects of

Open access
Nelma Veronica Marques Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Nelma Veronica Marques in
Google Scholar
PubMed
Close
,
Luiz Eduardo Armondi Wildemberg Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Luiz Eduardo Armondi Wildemberg in
Google Scholar
PubMed
Close
, and
Monica R Gadelha Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Monica R Gadelha in
Google Scholar
PubMed
Close

2.2 CSOM230B2219 ( 9 ) 20 39 M N Y N Octreotide LAR + cabergoline 3.4 CSOM230B2219 ( 9 ) Bold indicates late responders (after ≥4 months of treatment). a Defined as baseline glucose ≥ 126 mg/dL, HbA1c ≥ 6

Open access
The Working Group for Renaming Diabetes Insipidus
Search for other papers by The Working Group for Renaming Diabetes Insipidus in
Google Scholar
PubMed
Close
,
Hiroshi Arima Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
Japan Endocrine Society

Search for other papers by Hiroshi Arima in
Google Scholar
PubMed
Close
,
Timothy Cheetham Department of Paediatric Endocrinology, Newcastle University Faculty of Medical Sciences, Great North Children’s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, UK
European Society for Pediatric Endocrinology

Search for other papers by Timothy Cheetham in
Google Scholar
PubMed
Close
,
Mirjam Christ-Crain Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel, University of Basel, Switzerland
European Society of Endocrinology

Search for other papers by Mirjam Christ-Crain in
Google Scholar
PubMed
Close
,
Deborah Cooper Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel, University of Basel, Switzerland

Search for other papers by Deborah Cooper in
Google Scholar
PubMed
Close
,
Mark Gurnell European Society of Endocrinology
Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke’s Hospital, Cambridge Biomedical Campus, Cambridge, UK

Search for other papers by Mark Gurnell in
Google Scholar
PubMed
Close
,
Juliana B Drummond Faculdade de Medicina da UFMG, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Brazilian Society of Endocrinology and Metabolism

Search for other papers by Juliana B Drummond in
Google Scholar
PubMed
Close
,
Miles Levy Endocrinology, University Hospitals of Leicester, Leicester, UK
Society for Endocrinology

Search for other papers by Miles Levy in
Google Scholar
PubMed
Close
,
Ann I McCormack Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia
Endocrine Society of Australia

Search for other papers by Ann I McCormack in
Google Scholar
PubMed
Close
,
Joseph Verbalis Endocrinology and Metabolism, Georgetown University Medical Center, Washington DC, District of Columbia, USA
Endocrine Society

Search for other papers by Joseph Verbalis in
Google Scholar
PubMed
Close
,
John Newell-Price Endocrine Society
Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK

Search for other papers by John Newell-Price in
Google Scholar
PubMed
Close
, and
John A H Wass Department of Endocrinology, Oxford Centre for Diabetes Endocrinology & Metabolism – Endocrinology, Oxford, UK
Pituitary Society

Search for other papers by John A H Wass in
Google Scholar
PubMed
Close

inappropriately attributed to an individual who was not the first or even the most significant person involved in the description of the syndrome ( 2 ). A third reason is later appreciation of medically unethical behaviors of individuals with diseases eponymously

Open access
Chiara Jongerius Amsterdam UMC, Location AMC, Medical Psychology, Amsterdam, The Netherlands
Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands

Search for other papers by Chiara Jongerius in
Google Scholar
PubMed
Close
,
Marij A Hillen Amsterdam UMC, Location AMC, Medical Psychology, Amsterdam, The Netherlands
Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands

Search for other papers by Marij A Hillen in
Google Scholar
PubMed
Close
,
Ellen M A Smets Amsterdam UMC, Location AMC, Medical Psychology, Amsterdam, The Netherlands
Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands

Search for other papers by Ellen M A Smets in
Google Scholar
PubMed
Close
,
Mathijs J Mol Amsterdam UMC, Location AMC, Medical Psychology, Amsterdam, The Netherlands

Search for other papers by Mathijs J Mol in
Google Scholar
PubMed
Close
,
Eefje S Kooij Amsterdam UMC, Location AMC, Medical Psychology, Amsterdam, The Netherlands

Search for other papers by Eefje S Kooij in
Google Scholar
PubMed
Close
,
Maria A de Nood Amsterdam UMC, Location AMC, Medical Psychology, Amsterdam, The Netherlands

Search for other papers by Maria A de Nood in
Google Scholar
PubMed
Close
,
Edwin S Dalmaijer MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom

Search for other papers by Edwin S Dalmaijer in
Google Scholar
PubMed
Close
,
Eric Fliers Department of Endocrinology & Metabolism, Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands

Search for other papers by Eric Fliers in
Google Scholar
PubMed
Close
,
Johannes A Romijn Department of Medicine, Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands

Search for other papers by Johannes A Romijn in
Google Scholar
PubMed
Close
, and
Daniel S Quintana University of Oslo, Department of Psychology, Oslo, Norway
Department of Rare Disorders and Disabilities, Oslo University Hospital, NevSom, Oslo, Norway
University of Oslo, Norwegian Centre for Mental Disorders Research (NORMENT) and KG Jebsen Centre for Neurodevelopmental Disorders, Oslo, Norway

Search for other papers by Daniel S Quintana in
Google Scholar
PubMed
Close

). Oxytocin functions both as a neurotransmitter and as a hormone. Intranasally administered oxytocin has been used to investigate the effects of oxytocin on social cognition and behavior in humans ( 21 ) as it increases oxytocin concentrations in the central

Open access
Sherwin Criseno Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Close
,
Helena Gleeson Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Close
,
Andrew A Toogood Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Andrew A Toogood in
Google Scholar
PubMed
Close
,
Neil Gittoes Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Neil Gittoes in
Google Scholar
PubMed
Close
,
Anne Topping School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK

Search for other papers by Anne Topping in
Google Scholar
PubMed
Close
, and
Niki Karavitaki Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Niki Karavitaki in
Google Scholar
PubMed
Close

improvement on the 25-point QoL assessment scale (QoL-AGHDA) is demonstrated during the first 9 months of treatment. It remains uncertain, however, if the beneficial effects of GH administration are sustained throughout adult life. In fact, the few published

Open access
I M A A van Roessel Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by I M A A van Roessel in
Google Scholar
PubMed
Close
,
J E Gorter Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by J E Gorter in
Google Scholar
PubMed
Close
,
B Bakker Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by B Bakker in
Google Scholar
PubMed
Close
,
M M van den Heuvel-Eibrink Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by M M van den Heuvel-Eibrink in
Google Scholar
PubMed
Close
,
M H Lequin Department of Radiology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Radiology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by M H Lequin in
Google Scholar
PubMed
Close
,
J van der Lugt Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands

Search for other papers by J van der Lugt in
Google Scholar
PubMed
Close
,
L Meijer Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands

Search for other papers by L Meijer in
Google Scholar
PubMed
Close
,
A Y N Schouten-van Meeteren Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands

Search for other papers by A Y N Schouten-van Meeteren in
Google Scholar
PubMed
Close
, and
H M van Santen Department of Pediatric Neuro-oncology, Princess Máxima Center, Heidelberglaan, CS Utrecht, The Netherlands
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center, Lundlaan, EA Utrecht, The Netherlands

Search for other papers by H M van Santen in
Google Scholar
PubMed
Close

mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group . Lancet. Diabetes and Endocrinology 2021 9 622

Open access
Ichelle Maa van Roessel Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, AB Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands

Search for other papers by Ichelle Maa van Roessel in
Google Scholar
PubMed
Close
,
Boudewijn Bakker Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, AB Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands

Search for other papers by Boudewijn Bakker in
Google Scholar
PubMed
Close
,
Hanneke M van Santen Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, AB Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands

Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Close
, and
Wassim Chemaitilly Division of Pediatric Endocrinology, UPMC Children’s Hospitalof Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by Wassim Chemaitilly in
Google Scholar
PubMed
Close

the public, commercial or not-for-profit sector. References 1 Chemaitilly W Sklar CA . Childhood cancer treatments and associated endocrine late effects: a concise guide for the pediatric endocrinologist . Hormone Research in

Open access
Mette Marie Baunsgaard Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Mette Marie Baunsgaard in
Google Scholar
PubMed
Close
,
Anne Sophie Lind Helligsoe Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Anne Sophie Lind Helligsoe in
Google Scholar
PubMed
Close
,
Louise Tram Henriksen Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Louise Tram Henriksen in
Google Scholar
PubMed
Close
,
Torben Stamm Mikkelsen Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Torben Stamm Mikkelsen in
Google Scholar
PubMed
Close
,
Michael Callesen Department of Paediatrics, Odense University Hospital, Odense, Funen, Denmark

Search for other papers by Michael Callesen in
Google Scholar
PubMed
Close
,
Britta Weber The Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Britta Weber in
Google Scholar
PubMed
Close
,
Henrik Hasle Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Henrik Hasle in
Google Scholar
PubMed
Close
, and
Niels Birkebæk Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Niels Birkebæk in
Google Scholar
PubMed
Close

physical chronic late effects ( 15 ) with growth hormone deficiency (GHD) being the most common endocrinopathy ( 16 ) followed by thyroid-stimulating hormone deficiency ( 17 ). CR is the most significant risk factor for the development of GHD ( 18

Open access
I M A A van Roessel Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by I M A A van Roessel in
Google Scholar
PubMed
Close
,
J P de Graaf Dutch Pituitary Foundation, Nijkerk, The Netherlands
Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Endo-ERN European Reference Network on Rare endocrine conditions

Search for other papers by J P de Graaf in
Google Scholar
PubMed
Close
,
N R Biermasz Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Endo-ERN European Reference Network on Rare endocrine conditions

Search for other papers by N R Biermasz in
Google Scholar
PubMed
Close
,
E Charmandari Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Aghia Sophia Children's Hospital, Athens, Greece
Division of Endocrinology and Metabolism, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece

Search for other papers by E Charmandari in
Google Scholar
PubMed
Close
, and
H M van Santen Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by H M van Santen in
Google Scholar
PubMed
Close

of the late effects of their brain tumor treatment until they occurred and therefore did not feel prepared for these late effects. According to the patients, some doctors focus too much on survival rather than on quality of life. Patients

Open access